At this point there are many "razor" manufacturers and Arrayit is just one of them. Just as with Gillette, the money is not in the razor but rather, in the repeat selling of the blades. In keeping with the analogy, the blades in this case are the "tests" that can be developed compatible with this razor. In other words it is in the making and selling of the tests such as the allergy test, OvaDx, etc where the money is made. The more revenue generating tests and procedures a company can develop using that machine the better for the company. But do not think for a moment that once a company buys an Arrayit machine, and that machine is used to develop a unique test, that Arrayit is in on the profits generated by that machine. Thus it behooves Arrayit to be a developer and seller of tests rather than of machines. That's all I'm saying.
Market Data 
Markets 
